What is LOPJLB’s current signal on APMD?

LOPJLB’s latest quantitative signal on Apnimed, Inc. (APMD) is FLAT. Signals are updated daily.

What market regime is APMD in?

LOPJLB classifies each ticker into Bull, Recovery, Ranging, Bear, or Crisis regimes using a Hidden Markov Model.

What does Apnimed, Inc. (APMD) do?

Apnimed, Inc. operates as a clinical pharmaceutical company that develops and manufactures novel oral therapies that address the neurobiology of sleep-related breathing diseases in global markets. Its products include AD109, an oral therapy designed to treat obstructive sleep apnea (OSA) by targeting the underlying neuromuscular dysfunction. The company was incorporated in 2017 and is based in …

Where is Apnimed, Inc. based / listed?

Apnimed, Inc. is based in US, listed on NASDAQ.

Apnimed, Inc. (APMD)

Healthcare · Biotechnology · NASDAQ · US

$28.03-1.82%Close

FLAT

[SCORES & PROFILE]

FUND: 18
VALUE: 8
GROWTH: 20
GARP: 21
TYPE: Growth Compounder

Composite of Value · Growth · GARP

ROIC-

REV YoY2608.8%

ROE-

EPS YoY-

ROA-

---

[VALUATION]

P/E TTM-

P/E FWD-

SECTOR PE22.60

INDUSTRY PE17.46

P/B-

P/FCF-

EV/EBITDA-

EV/EBIT-

PEG-

FCF YIELD-

RISK

INT COV-

D/E-

ALTMAN Z-

CURR RATIO-

ND/EBITDA-0.18

BETA0.00

Apnimed, Inc. (APMD)

Key stats

Sector peers

Prediction markets

FUNDAMENTALS

Company news